Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting von Straka, Robert J, Liu, Larry Z, Girase, Prafulla S, DeLorenzo, Allyson, Chapman, Richard H

Volltext

Determining initial and follow-up costs of cardiovascular events in a US managed care population von Chapman, Richard H, Liu, Larry Z, Girase, Prafulla G, Straka, Robert J

Volltext

Retrospective evaluation of outcomes in patients with overactive bladder receiving tolterodine versus oxybutynin von Jumadilova, Zhanna, Varadharajan, Sujata, Girase, Prafulla, Ollendorf, Daniel A

Volltext

Generic and therapeutic statin switches and disruptions in therapy von Chapman, Richard H., Benner, Joshua S., Girase, Prafulla, Benigno, Michael, Axelsen, Kirsten, Liu, Larry Z., Nichol, Michael B.

Volltext

Economic impact of extended-release tolterodine versus immediate- and extended-release oxybutynin among commercially insured persons with overactive bladder von Varadharajan, Sujata, Jumadilova, Zhanna, Girase, Prafulla, Ollendorf, Daniel A

Volltext